Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Baxter Reports Third-Quarter 2018 Results and Updates Financial Outlook for Full-Year 2018
October 31, 2018 7:15 AM EDTThird-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 3 percent on an operational basis Third-quarter GAAP earnings per share (EPS) of $1.00; Adjusted EPS of $0.80 increased 25 percent Company expects full-year 2018 sales growth of approximately 5 percent on a reported basis and approximately 3 percent on an operational basis Company expects full-year 2018 GAAP EPS of $2.90 to $2.94; Adjusted EPS of $2.98 to $3.00
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today... More
